Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9688 |
High Similarity |
NPD1240 |
Approved |
0.9538 |
High Similarity |
NPD1607 |
Approved |
0.9394 |
High Similarity |
NPD1510 |
Phase 2 |
0.9254 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9254 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9203 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9185 |
High Similarity |
NPD1549 |
Phase 2 |
0.8929 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8897 |
High Similarity |
NPD2796 |
Approved |
0.875 |
High Similarity |
NPD4380 |
Phase 2 |
0.8723 |
High Similarity |
NPD6799 |
Approved |
0.8699 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.869 |
High Similarity |
NPD7411 |
Suspended |
0.8676 |
High Similarity |
NPD6651 |
Approved |
0.8639 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8633 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.863 |
High Similarity |
NPD1934 |
Approved |
0.8592 |
High Similarity |
NPD1511 |
Approved |
0.8571 |
High Similarity |
NPD2801 |
Approved |
0.8523 |
High Similarity |
NPD7075 |
Discontinued |
0.8519 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8493 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8489 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8472 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8456 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8446 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8446 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.84 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.838 |
Intermediate Similarity |
NPD3750 |
Approved |
0.838 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8378 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8357 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.831 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.831 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8261 |
Intermediate Similarity |
NPD943 |
Approved |
0.8212 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD2654 |
Approved |
0.8169 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8158 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8151 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8151 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8151 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8148 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8146 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8141 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8117 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8088 |
Intermediate Similarity |
NPD2798 |
Approved |
0.806 |
Intermediate Similarity |
NPD3972 |
Approved |
0.8056 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8041 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8038 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8028 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8028 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8028 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7975 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7971 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7945 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7939 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7937 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7926 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7925 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7925 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7919 |
Intermediate Similarity |
NPD920 |
Approved |
0.7905 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7891 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7877 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7875 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7857 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7857 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7852 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7847 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7842 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.784 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7826 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7821 |
Intermediate Similarity |
NPD5494 |
Approved |
0.782 |
Intermediate Similarity |
NPD9545 |
Approved |
0.782 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.78 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7754 |
Intermediate Similarity |
NPD2797 |
Approved |
0.773 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7721 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7673 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7669 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7591 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7582 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7569 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7554 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7554 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7536 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7535 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7534 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7534 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD919 |
Approved |
0.7517 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1470 |
Approved |
0.75 |
Intermediate Similarity |
NPD5710 |
Approved |
0.75 |
Intermediate Similarity |
NPD3267 |
Approved |
0.75 |
Intermediate Similarity |
NPD1164 |
Approved |
0.75 |
Intermediate Similarity |
NPD5711 |
Approved |
0.75 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7448 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7438 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7432 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7402 |
Intermediate Similarity |
NPD846 |
Approved |
0.7402 |
Intermediate Similarity |
NPD940 |
Approved |
0.74 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7394 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7384 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7384 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7365 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7361 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7361 |
Intermediate Similarity |
NPD411 |
Approved |
0.7357 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7342 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7341 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7341 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7329 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7328 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7328 |
Intermediate Similarity |
NPD74 |
Approved |
0.7324 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7319 |
Intermediate Similarity |
NPD17 |
Approved |
0.7299 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7286 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD9494 |
Approved |
0.726 |
Intermediate Similarity |
NPD1613 |
Approved |
0.726 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7252 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7252 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7252 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7252 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7246 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7237 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7234 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7214 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7211 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7208 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4661 |
Approved |
0.72 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7183 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7174 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7124 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7113 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD37 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7107 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7103 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7083
|
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |